← All events · South Sudan report
South Sudan: Strategic developments in South Sudan
Starting but Not Finishing: The Malaria Vaccine Challenge in South Sudan - Findings from the Malaria Vaccine Post-Introduction Evaluation (PIE) (October 2026) Country: South Sudan Source: World Health Organization Please refer to the attached file. Why Malaria Vaccination Matters Malaria remains one of the leading causes of illness and death among children under five in South Sudan. To strengthen protection against severe malaria, the country introduced the malaria vaccine in 28 counties in July 2024 and expanded it nationwide to all 80 counties by August 2025. The vaccine is delivered in four doses at 5, 6, 7 and 18 months of age and complements existing malaria prevention interventions, including insecticide-treated nets and intermittent preventive treatment in pregnancy (IPTp). The fourth dose is delivered alongside the second dose of measles-containing vaccine (MCV2), creating an opportunity to strengthen immunization services during the second year of life. The Post Introduction Evaluation (PIE) assessed how well the vaccine has been integrated into routine immunization services and identified opportunities to improve vaccination completion, service delivery, data quality, and equitable access. This factsheet summarizes findings from the Post Introduction Evaluation and highlights opportunities to improve completion of the four-dose malaria vaccine schedule, particularly for children in the second year of life.
Event details
These categories are assigned by an automated classifier and are not manually verified — they can be inaccurate or mislabelled. See how Newsmap classifies events.
Source
This event was reported on rssby @ReliefWeb. The summary above is an automated, neutral description; always consult the original report before relying on it.
Related reports
Other recent reports about the same actors or country: